Roles of inflammation response in microglia cell through Toll-like receptors 2/interleukin-23/interleukin-17 pathway in cerebral ischemia/reperfusion injury

Neuroscience. 2011 Mar 10:176:162-72. doi: 10.1016/j.neuroscience.2010.11.066. Epub 2010 Dec 20.

Abstract

Microglial activation is one of the causative factors of neuroinflammation in cerebral ischemia. Activation via Toll-like receptors (TLRs) causes increased proinflammatory cytokine expression, such as interleukin-23 (IL-23) and interleukin-17 (IL-17), leading to inflammatory immune responses and neuronal damage. In this study, using a rat focal cerebral ischemia reperfusion (IR) model and an in vitro oxygen-glucose deprivation reperfusion (OGDR) system, we found that TLR2, IL-23 and IL-17 form an axis that leads to increased neuronal apoptosis. TLR2 activation results in IL-23 production which stimulates IL-17 production by microglia. This microglial axis may be a potential therapeutic target to control neuroinflammation in brain IR.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / physiology
  • Blotting, Western
  • Brain Ischemia / immunology
  • Brain Ischemia / metabolism*
  • Brain Ischemia / pathology
  • Cells, Cultured
  • Enzyme-Linked Immunosorbent Assay
  • Immunohistochemistry
  • In Situ Nick-End Labeling
  • Inflammation / immunology
  • Inflammation / metabolism*
  • Inflammation / pathology
  • Interleukin-17 / metabolism*
  • Interleukin-23 / metabolism*
  • Male
  • Microglia / immunology
  • Microglia / metabolism*
  • Neurons / pathology
  • RNA, Small Interfering
  • Rats
  • Rats, Sprague-Dawley
  • Reperfusion Injury / immunology
  • Reperfusion Injury / metabolism
  • Reperfusion Injury / pathology
  • Signal Transduction / physiology
  • Toll-Like Receptor 2 / metabolism*
  • Transfection

Substances

  • Interleukin-17
  • Interleukin-23
  • RNA, Small Interfering
  • Tlr2 protein, rat
  • Toll-Like Receptor 2